Hydroxychloroquinesulfaat Cf (Hydroxychloroquine)

Hydroxychloroquine works by two main mechanisms. It interferes with the parasite’s ability to detoxify heme, leading to toxic buildup that kills malaria organisms. In immune cells, it raises lysosomal pH, which disrupts antigen processing and lowers cytokine production, thereby dampening the inflammatory response seen in rheumatoid arthritis and lupus.

The appropriate dose of Hydroxychloroquinesulfaat Cf is determined by the prescribing clinician based on the specific indication, patient weight, renal function, and other clinical factors. Healthcare professionals tailor the regimen to achieve therapeutic goals while minimizing risk, and patients should follow the exact instructions provided by their prescriber.

Safety data for hydroxychloroquine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Hydroxychloroquine offers a favorable safety profile compared with some alternative antimalarials and disease‑modifying antirheumatic drugs (DMARDs). Unlike chloroquine, it has a lower risk of retinal toxicity at recommended doses, and compared with biologic DMARDs, it is administered orally and does not require injection or infusion, making it more convenient for many patients.

Hydroxychloroquinesulfaat Cf should be stored at room temperature, below 25 °C, in its original packaging. The container should be kept tightly closed, protected from moisture and direct sunlight to maintain product stability throughout its shelf life.

The product is intended for oral administration. Patients should swallow the tablet whole with a glass of water, preferably with food to reduce gastrointestinal discomfort. The exact timing and frequency are prescribed by the treating physician based on the indication and individual patient factors.

Serious risks include retinal toxicity, which can lead to irreversible vision loss, and cardiac effects such as QT‑interval prolongation or cardiomyopathy. Additionally, severe hypoglycemia, blood dyscrasias, and rare but life‑threatening skin reactions may occur. Regular monitoring and prompt reporting of symptoms are essential to mitigate these risks.

Hydroxychloroquinesulfaat Cf is contraindicated in patients with known hypersensitivity to hydroxychloroquine or related compounds. Individuals with pre‑existing retinal disease, significant cardiac conduction abnormalities, or severe liver or kidney impairment should avoid use unless a specialist determines that benefits outweigh the risks.